STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
comments(0)
5-min edit window · permanent after that